Paragon Capital Management LLC Invests $35,000 in Clorox Co (CLX) Stock

Paragon Capital Management LLC acquired a new position in Clorox Co (NYSE:CLX) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 218 shares of the company’s stock, valued at approximately $35,000.

A number of other institutional investors have also recently bought and sold shares of CLX. Visionary Asset Management Inc. purchased a new position in shares of Clorox during the fourth quarter worth approximately $225,000. Phocas Financial Corp. purchased a new position in shares of Clorox during the fourth quarter worth approximately $193,000. Oregon Public Employees Retirement Fund increased its position in shares of Clorox by 48,033.6% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 6,808,980 shares of the company’s stock worth $44,000 after acquiring an additional 6,794,834 shares during the period. Montecito Bank & Trust increased its position in shares of Clorox by 24.0% during the first quarter. Montecito Bank & Trust now owns 5,212 shares of the company’s stock worth $836,000 after acquiring an additional 1,009 shares during the period. Finally, W.E. Donoghue & Co. LLC purchased a new position in shares of Clorox during the fourth quarter worth approximately $2,482,000. 76.89% of the stock is currently owned by institutional investors.

CLX has been the topic of a number of research reports. Wells Fargo & Co reaffirmed a “hold” rating and set a $157.00 target price on shares of Clorox in a research report on Monday, February 4th. Zacks Investment Research raised shares of Clorox from a “sell” rating to a “hold” rating in a research report on Monday, January 7th. Citigroup set a $171.00 target price on shares of Clorox and gave the stock a “hold” rating in a research report on Tuesday, February 5th. JPMorgan Chase & Co. lowered shares of Clorox from a “neutral” rating to an “underweight” rating and reduced their target price for the stock from $159.00 to $139.00 in a research report on Monday, April 8th. Finally, Morgan Stanley set a $142.00 target price on shares of Clorox and gave the stock a “sell” rating in a research report on Thursday, December 20th. Six analysts have rated the stock with a sell rating, five have issued a hold rating and four have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus target price of $151.21.

In other Clorox news, SVP Matthew T. Laszlo sold 10,585 shares of the firm’s stock in a transaction that occurred on Wednesday, February 6th. The shares were sold at an average price of $153.89, for a total value of $1,628,925.65. Following the completion of the sale, the senior vice president now directly owns 17,994 shares in the company, valued at $2,769,096.66. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, SVP Andrew J. Mowery sold 5,340 shares of the firm’s stock in a transaction that occurred on Friday, March 1st. The shares were sold at an average price of $156.44, for a total transaction of $835,389.60. The disclosure for this sale can be found here. 1.40% of the stock is currently owned by company insiders.

Shares of NYSE CLX traded down $1.04 during midday trading on Monday, reaching $154.45. 772,492 shares of the company’s stock traded hands, compared to its average volume of 990,674. The company has a debt-to-equity ratio of 3.08, a quick ratio of 0.66 and a current ratio of 1.15. Clorox Co has a one year low of $113.57 and a one year high of $167.70. The company has a market cap of $19.87 billion, a PE ratio of 24.67, a P/E/G ratio of 3.87 and a beta of 0.32.

Clorox (NYSE:CLX) last released its quarterly earnings data on Monday, February 4th. The company reported $1.40 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.32 by $0.08. Clorox had a net margin of 12.65% and a return on equity of 105.97%. The firm had revenue of $1.47 billion for the quarter, compared to the consensus estimate of $1.47 billion. During the same period last year, the firm earned $1.77 earnings per share. The company’s quarterly revenue was up 4.0% on a year-over-year basis. On average, analysts forecast that Clorox Co will post 6.31 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 10th. Stockholders of record on Wednesday, April 24th will be paid a dividend of $0.96 per share. The ex-dividend date is Tuesday, April 23rd. This represents a $3.84 dividend on an annualized basis and a dividend yield of 2.49%. Clorox’s dividend payout ratio is presently 61.34%.

ILLEGAL ACTIVITY NOTICE: This piece was published by WKRB News and is owned by of WKRB News. If you are viewing this piece on another site, it was stolen and republished in violation of US & international copyright and trademark law. The original version of this piece can be read at https://www.wkrb13.com/2019/04/15/paragon-capital-management-llc-invests-35000-in-clorox-co-clx-stock.html.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Further Reading: What are retained earnings?

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.